hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 63 No. 2, 2013.

Izvorni znanstveni članak
https://doi.org/10.2478/acph-2013-0014

Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives

IVAN KOS ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
MILENA JADRIJEVIĆ-MLADAR TAKAČ ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
IVAN BUTULA ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
MLADEN BIRUŠ ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
GORDANA MARAVIĆ-VLAHOVIČEK ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
SANJA DABELIĆ ; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Puni tekst: engleski, pdf (184 KB) str. 175-191 preuzimanja: 625* citiraj
APA 6th Edition
KOS, I., JADRIJEVIĆ-MLADAR TAKAČ, M., BUTULA, I., BIRUŠ, M., MARAVIĆ-VLAHOVIČEK, G. i DABELIĆ, S. (2013). Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives. Acta Pharmaceutica, 63 (2), 175-191. https://doi.org/10.2478/acph-2013-0014
MLA 8th Edition
KOS, IVAN, et al. "Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives." Acta Pharmaceutica, vol. 63, br. 2, 2013, str. 175-191. https://doi.org/10.2478/acph-2013-0014. Citirano 22.02.2019.
Chicago 17th Edition
KOS, IVAN, MILENA JADRIJEVIĆ-MLADAR TAKAČ, IVAN BUTULA, MLADEN BIRUŠ, GORDANA MARAVIĆ-VLAHOVIČEK i SANJA DABELIĆ. "Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives." Acta Pharmaceutica 63, br. 2 (2013): 175-191. https://doi.org/10.2478/acph-2013-0014
Harvard
KOS, I., et al. (2013). 'Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives', Acta Pharmaceutica, 63(2), str. 175-191. doi: https://doi.org/10.2478/acph-2013-0014
Vancouver
KOS I, JADRIJEVIĆ-MLADAR TAKAČ M, BUTULA I, BIRUŠ M, MARAVIĆ-VLAHOVIČEK G, DABELIĆ S. Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives. Acta Pharm. [Internet]. 2013 [pristupljeno 22.02.2019.];63(2):175-191. doi: https://doi.org/10.2478/acph-2013-0014
IEEE
I. KOS, M. JADRIJEVIĆ-MLADAR TAKAČ, I. BUTULA, M. BIRUŠ, G. MARAVIĆ-VLAHOVIČEK i S. DABELIĆ, "Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives", Acta Pharmaceutica, vol.63, br. 2, str. 175-191, 2013. [Online]. doi: https://doi.org/10.2478/acph-2013-0014

Sažetak
Synthesis and biological evaluation for a series (N = 16) of cyclic and acyclic hydroxyurea derivatives including benzotriazole-, isocyanuirc acid- and biuret-containing compounds, are disclosed. 1-N-(benzyloxycarbamoyl)benzotriazole was used as benzyloxyisocyanate donor, a useful intermediate in the preparation of substituted hydroxyurea. Antibacterial activities of synthesized hydroxyurea derivatives were tested on three E. coli strains, i.e., strain susceptible to antibiotics, strain resistant to macrolide antibiotics and strain resistant to aminoglycoside antibiotics. Six compounds (three acyclic and three cyclic hydroxyureas) showed the growth inhibition of tested E. coli strains, with different specificity toward each strain. Results of the cytotoxic activity evaluation revealed that twelve out of sixteen test compounds were cytotoxic to human acute monocytic leukemia THP-1 and/or on human acute T cell leukemia Jurkat cell line. 1-(N-hydroxycarbamoyl)benzotriazole (5) increased metabolic activity of both cell lines. Two compounds, 1-(N-hydroxycarbamoyl)benzotriazole (5) and N,N’,N’’-trihydroxybiuret (15) were identified as potential NO donors.

Ključne riječi
hydroxyurea derivatives; synthesis; antibacterial activity; cytotoxicity

Hrčak ID: 97696

URI
https://hrcak.srce.hr/97696

Posjeta: 794 *